Salesforce Inc (CRM) Stock Analysis

Verdict: BUY

Agentforce AI monetization and $14.4B FCF drive structural re-acceleration, but elevated debt from buybacks and seat-compression risks cap momentum.

Investment score: 67/100

Analysis as of

Is Salesforce Inc stock worth reviewing? AI model thesis

The model rates Salesforce (CRM) as a BUY with a 72% confidence score based on re-accelerating cRPO growth of 14% YoY, an attractive 7.8% FCF yield, and surging Agentforce AI adoption ($1.5B ARR).

7-factor investment score

Salesforce Inc opportunities and risks

What speaks for CRM

What speaks against CRM

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
CRM21.4x4.4x13.6x77.3%22.0%7.8%
PLTR159.5x75.1x148.6x84.8%49.0%0.7%
DDOG541.7x24.4x325.2x79.5%4.5%1.2%
ADBE13.4x3.7x9.6x89.1%28.0%11.4%
SNPS83.3x9.8x26.5x72.4%11.4%3.0%
CDNS65.1x15.5x40.3x85.9%23.6%1.9%
Peer median83.3x15.5x40.3x84.8%23.6%1.9%

Frequently asked questions about Salesforce Inc (CRM)

Is CRM stock a good investment?

The cached TradeMates AI model rates Salesforce Inc as BUY with an investment score of 67/100. The model rates Salesforce (CRM) as a BUY with a 72% confidence score based on re-accelerating cRPO growth of 14% YoY, an attractive 7.8% FCF yield, and surging Agentforce AI adoption ($1.5B ARR). This is algorithmic model output, not personal investment advice.

Is CRM stock a buy?

The TradeMates model verdict for CRM is BUY with an investment score of 67/100. Treat this as a model signal to review, not a personal buy recommendation.